Live Cell Imaging Ramona's Vireo live cell imaging system launched in January 2025 signals growing demand for real-time, high-resolution cellular workflows. Sales opportunities include targeting pharma and biotech R&D teams focused on drug discovery, offering Vireo-based pilots or bundles with MCAM capabilities, and providing training, integration support, and analytics to accelerate adoption.

MCAM Advantage The multi-camera array microscope MCAM differentiates Ramona's offering by enabling dynamic imaging across space and time. A sales angle is to pursue labs requiring large field-of-view without sacrificing resolution, targeting cancer biology, neuroscience, and developmental biology groups, and offering bundled packages that combine MCAM, Vireo, color map software, and data analytics.

Cloud and Data Ramona's technology stack includes Google Cloud Platform, Amazon S3, and data oriented tools like DataCamp, suggesting a natural fit for cloud based data workflows. Opportunity: position Ramona as a data management and analytics partner for labs generating large imaging datasets, offering scalable storage, processing pipelines, and collaboration ready software integrations.

Midmarket Growth Ramona's size places it in the midmarket segment with growing life sciences budgets among target customers. Opportunity: pursue long term contracts with mid-size pharma and CROs, offer pilots, and scale through recurring revenue via software licenses, support, and data services.

Content Driven Ramona maintains active content channels, including Medium updates and YouTube demos, to showcase data and results from MCAM products. Opportunity: leverage these assets to drive outbound and inbound sales, run webinars, create customer success stories, and partner with research institutions for co marketing and pilots.